Recordati 1H Net Rev Climbs 12% to €1.3 Bln on Rare Diseases Unit Strength

By Daniella Parra Recordati, an international pharmaceutical company said its consolidated net revenue rose 12% to €1.3 billion in the first half of 2025. Rare Diseases revenue was €515.7 million for the first half of 2025, up 29.2% as compared...